Comparative Pharmacology
Head-to-head clinical analysis: CARBOCAINE W NEO COBEFRIN versus POLOCAINE W LEVONORDEFRIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CARBOCAINE W NEO COBEFRIN versus POLOCAINE W LEVONORDEFRIN.
CARBOCAINE W/ NEO-COBEFRIN vs POLOCAINE W/ LEVONORDEFRIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mepivacaine is an amide-type local anesthetic that blocks sodium ion channels in nerve cell membranes, inhibiting nerve impulse conduction. Neo-cobefrin (levonordefrin) is a vasoconstrictor that acts on alpha-adrenergic receptors to constrict blood vessels, prolonging mepivacaine's action.
Polocaine (mepivacaine) is an amide local anesthetic that blocks sodium ion channels in nerve cell membranes, inhibiting the initiation and conduction of nerve impulses. Levonordefrin is a vasoconstrictor that acts as an alpha-adrenergic agonist, causing local vasoconstriction to reduce systemic absorption of mepivacaine and prolong duration of action.
1-2% mepivacaine with 1:200,000 levonordefrin. Maximum dose: mepivacaine 400 mg (5 mg/kg); for dental infiltration: 0.5-1.8 mL, nerve block: 0.9-3.6 mL, epidural: 15-30 mL of 1% or 2% solution.
Dental local anesthesia: 1:100,000 epinephrine equivalent. For Polocaine (mepivacaine) 2% with levonordefrin 1:20,000, typical adult dose: 1-3 mL infiltrations or 2-4 mL nerve blocks; maximum 6.8 mg/kg (mepivacaine) or about 5.8 mL of 2% solution for a 70 kg adult. Maximum per session: 20 mL of 2% mepivacaine.
None Documented
None Documented
Terminal elimination half-life ~2-3 hours; prolonged in hepatic impairment; clinical context: short duration of action
Terminal elimination half-life of prilocaine is approximately 1.5 hours (range 1-2 hours); clinically, this correlates with duration of anesthesia for infiltration and nerve block procedures.
Renal excretion of unchanged drug and metabolites; ~1-2% unchanged in urine; hepatic metabolism to inactive metabolites; biliary/fecal elimination minimal
Renal excretion of unchanged drug and metabolites accounts for >90% of elimination; <2% excreted unchanged in urine; major metabolites are glucuronide and sulfate conjugates excreted renally; biliary excretion is minor.
Category C
Category C
Local Anesthetic Combination
Local Anesthetic Combination